STOCK TITAN

Transcat - TRNS STOCK NEWS

Welcome to our dedicated page for Transcat news (Ticker: TRNS), a resource for investors and traders seeking the latest updates and insights on Transcat stock.

Overview of Transcat Inc

Transcat Inc is a distinguished provider of accredited calibration, repair, inspection, and compliance services, integrating advanced laboratory instrument services with a robust distribution arm. Key industry-specific terms such as calibration, laboratory instrument services, and ISO accreditation are pivotal in illustrating its deep-rooted technical expertise. The company operates through two primary segments: the Service segment which focuses on calibration and validation services, and the Distribution segment which supplies professional-grade test, measurement, and control instrumentation.

Core Services and Capabilities

The Service segment of Transcat Inc is engineered to offer comprehensive solutions in the realms of analytical instrument qualifications, equipment validation, and process inspection. Emphasizing precision, the firm addresses an extensive range of measurement parameters through its adherence to ISO/IEC 17025 accreditation standards. This rigorous quality framework reinforces the reliability of its services across various compliance-heavy industries such as medical devices, life science, biotechnology, and pharmaceuticals.

Industry Applications and Market Position

Transcat Inc has strategically positioned itself within several regulated and manufacturing intensive industries. Its service portfolio is tailored to meet the stringent needs of FDA-regulated sectors including pharmaceutical and medical device industries, as well as industrial manufacturing, energy, utilities, and chemical processing. This multi-industry focus not only diversifies its revenue streams but also reinforces its reputation as a dependable and versatile service provider.

Distribution Segment and Product Offerings

Alongside its services, Transcat Inc operates a well-integrated Distribution segment. This division specializes in marketing and distributing a broad range of professional-grade handheld test, measurement, and control instruments. By collaborating with renowned brand names, the company ensures that customers have access to premier and proprietary product lines, which complement the precision and reliability of its calibration services.

Operational Excellence and Quality Assurance

With over 20 strategically located centers of excellence across the United States, Canada, and Puerto Rico, Transcat Inc demonstrates a commitment to operational efficiency and quality. The company leverages its widespread network to ensure prompt turnaround times and accurate service delivery. The stringent application of internationally recognized standards underpins its operational protocols, providing a consistent and transparent framework that enhances both customer confidence and compliance adherence.

Competitive Differentiation and Strategic Value

Transcat Inc differentiates itself through its dual-operating model which combines an extensive service portfolio with a dedicated distribution network. This integration allows the firm to serve as a single-source partner for industries that demand both precision in calibration and high-quality instrumentation. Its ability to maintain accreditation across diverse measurement parameters and a robust geographic footprint underlines its strategic importance in regulated markets.

Conclusion

In summary, Transcat Inc stands out by delivering a comprehensive suite of services and products that assure quality, compliance, and operational precision. Its commitment to rigorous accreditation standards and extensive industry expertise cements its role as a critical resource for organizations in regulated and industrial sectors. The company’s balanced focus on both calibration services and the distribution of high-quality test instruments positions it as a trusted entity within its competitive landscape.

Rhea-AI Summary

Transcat, Inc. (TRNS) reported third-quarter revenue of $50.9 million, a 15.5% increase from the previous year. The service segment's organic revenue grew by 10.2%, contributing to a gross margin expansion of 180 basis points to 29.7%. Adjusted EBITDA rose by 20% to $5.5 million. Despite robust demand, the distribution segment's revenue growth of 7.2% was below expectations due to longer vendor lead times. The company anticipates continued strong performance in the upcoming fiscal quarter and maintains a healthy backlog of $9 million.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-12.94%
Tags
none
-
Rhea-AI Summary

Transcat, Inc. (NASDAQ: TRNS) will announce its third quarter fiscal year 2022 results on February 1, 2022, after market close. The company will host a conference call on February 2, 2022, at 11:00 a.m. ET, to review financial and operational results alongside its corporate strategy and future outlook. Transcat, a leader in providing calibration, repair, and laboratory services, aims to leverage its dual service and distribution segments to fuel organic sales growth and expand its market share through strategic acquisitions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.81%
Tags
-
Rhea-AI Summary

Transcat, Inc. (Nasdaq: TRNS) has acquired Tangent Labs, LLC for $9 million, effective December 31, 2021. Tangent, specializing in precision calibration for regulated sectors such as life science and aerospace, generates approximately $2.2 million in annual revenue. This acquisition aligns with Transcat's expansion strategy, providing new presences in key markets, particularly in Indiana and Huntsville, Alabama. Kevin Broderick, Tangent's owner, will integrate into Transcat's leadership, enhancing the company's existing service capabilities to drive further profitability.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.63%
Tags
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.87%
Tags
none
-
Rhea-AI Summary

Transcat, Inc. (NASDAQ: TRNS) will participate in the Sidoti Virtual Micro Cap Investor Conference on December 8, 2021. CEO Lee D. Rudow and CFO Mark A. Doheny will present at 9:15 a.m. ET and are available for investor meetings. A link to the live webcast and presentation materials can be found on their investor relations page. Transcat specializes in accredited calibration, repair, inspection, and laboratory services, catering to regulated industries such as Life Sciences and Aerospace.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.94%
Tags
conferences
-
Rhea-AI Summary

Transcat, Inc. (NASDAQ: TRNS) reported a strong second quarter for fiscal 2022, with consolidated revenue reaching $50.4 million, a 21.1% increase year-over-year. The Service segment revenue rose 20.3% to $29.5 million, while the Distribution segment saw a 22.2% increase to $20.8 million. Gross margins improved, with the Service segment at 32.9% and Distribution at 23.5%. Adjusted EBITDA rose 35.5% to $7.1 million. Operating expenses included one-time costs from the NEXA acquisition, totaling $0.8 million. The company expects continued growth in the third quarter, driven by organic and acquisition-related revenue.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7%
Tags
none
Rhea-AI Summary

Transcat, Inc. (NASDAQ: TRNS) is set to release its second quarter fiscal year 2022 results on November 2, 2021, after market close. Following the announcement, a conference call will be held on November 3, 2021, at 11:00 a.m. ET to discuss the financial outcomes and corporate strategy. The Company's services focus on calibration and instrument distribution across regulated sectors, enhancing its competitive edge. Transcat aims to boost organic sales growth through strategic acquisitions and investments in its service capabilities.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.35%
Tags
-
Rhea-AI Summary

Transcat, Inc. (NASDAQ: TRNS), a leader in calibration and laboratory services, will present at the H.C. Wainwright 23rd Annual Global Investment Conference from September 13-15, 2021. CEO Lee D. Rudow and CFO Mark A. Doheny will deliver a pre-recorded presentation available from 7:00 am ET on September 13th. The presentation materials will also be accessible on Transcat's investor relations website, with a replay available for 60 days. Transcat focuses on regulated industries and aims to enhance organic sales growth through strategic acquisitions and investments.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.99%
Tags
conferences
-
Rhea-AI Summary

Transcat, Inc. (NASDAQ: TRNS) announced the acquisition of Cal Opex Limited, now known as NEXA Enterprise Asset Management, for $22.5 million, comprising $20.25 million in cash and $2.25 million in stock. The deal, effective August 31, 2021, includes potential earn-out payments of up to $7.5 million based on revenue and EBITDA goals. NEXA, focusing on reliability management for regulated industries, generated $7.5 million in annual revenue and has a strong profitability profile. This acquisition is expected to enhance Transcat's growth in calibration and asset management services.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.79%
Tags
Rhea-AI Summary

Transcat, Inc. (NASDAQ: TRNS) recently announced that CEO Lee D. Rudow and CFO Mark A. Doheny will present at the Oppenheimer Technology, Internet and Communications Virtual Conference on August 11, 2021, starting at 8:15 AM ET. Investors can access the live webcast and materials at transcat.com/investor-relations. The replay will be available for 60 days. Transcat offers accredited calibration, inspection, and repair services, focusing on highly regulated industries, and aims to drive organic growth through strategic expansions and enhanced service offerings.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.45%
Tags
conferences

FAQ

What is the current stock price of Transcat (TRNS)?

The current stock price of Transcat (TRNS) is $71.11 as of March 10, 2025.

What is the market cap of Transcat (TRNS)?

The market cap of Transcat (TRNS) is approximately 674.2M.

What are the primary business segments of Transcat Inc?

Transcat Inc operates through two main segments: a comprehensive services segment providing calibration, repair, inspection, and compliance services, and a distribution segment that markets professional-grade test, measurement, and control instruments.

How does Transcat Inc ensure the accuracy and reliability of its calibration services?

The company adheres strictly to internationally recognized standards, including ISO/IEC 17025, ensuring each calibration and validation process meets rigorous quality and precision criteria.

Which industries does Transcat Inc serve?

Transcat Inc serves a multitude of sectors including life sciences, biotechnology, pharmaceutical, medical device, industrial manufacturing, energy, and chemical processing industries, especially those requiring FDA compliance.

What types of products does the Distribution segment offer?

The Distribution segment of Transcat Inc offers a broad range of professional-grade handheld test, measurement, and control instrumentation sourced from both premier and proprietary brands.

How do Transcat Inc's services support regulatory compliance?

By following stringent accreditation protocols such as ISO/IEC 17025 and focusing on detailed inspection and validation services, Transcat Inc helps its clients maintain compliance with industry regulations.

What distinguishes Transcat Inc's operations in the market?

The firm's dual-operating model, strategic network of centers across North America, and its commitment to precision and quality enable it to offer a unique combination of calibration services and high-quality instrumentation distribution.

Can you explain the role of ISO/IEC 17025 accreditation in Transcat’s operations?

ISO/IEC 17025 accreditation is central to Transcat Inc’s operational integrity, ensuring that its calibration and testing services meet international standards for quality and accuracy, thus building trust with its clients.

How does Transcat Inc integrate its service and distribution segments?

The integration allows for a seamless approach where precision calibration services support the effective use of high-quality test and measurement instruments, offering clients a comprehensive solution from a single provider.
Transcat

Nasdaq:TRNS

TRNS Rankings

TRNS Stock Data

674.19M
9.04M
2.45%
93.83%
3.77%
Industrial Distribution
Instruments for Meas & Testing of Electricity & Elec Signals
Link
United States
ROCHESTER